Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A adenosine receptor

Stefania Merighi1, Annalisa Benini, Prisco Mirandola

  • 1Department of Clinical and Experimental Medicine, Pharmacology Section, University of Ferrara, Via Fossato di Mortara 17-19, 44100, Ferrara, Italy.

Purinergic Signalling
|April 12, 2008
PubMed

Insights

Investigating adenosine A₃ receptor signaling reveals key molecular pathways like PI3K/Akt and MAPK/ERK, crucial for controlling cell death and proliferation.

Area of Science:

  • Molecular biology
  • Cell signaling

Background:

  • Adenosine A₃ receptor (A₃AR) signaling is critical for regulating cell death and proliferation.
  • Understanding the downstream molecular pathways activated by A₃AR is essential for therapeutic development.

Purpose of the Study:

  • To review the downstream mediators of adenosine A₃ receptor signaling.
  • To elucidate the roles of phosphatidylinositide-3-OH kinase (PI3K)/Akt and Raf/mitogen-activated protein kinase (MAPK/ERK) pathways in A₃AR signaling.

Main Methods:

  • Literature review focusing on A₃AR downstream signaling.
  • Analysis of molecular pathways involved in cell survival and proliferation.

Main Results:

  • A₃AR stimulation influences cell death and proliferation through specific molecular pathways.
  • The PI3K/Akt and MAPK/ERK pathways are central to A₃AR-mediated cellular responses.
  • Investigated the crosstalk between these critical signaling cascades.

Conclusions:

  • A₃AR signaling modulates cell fate via PI3K/Akt and MAPK/ERK pathways.
  • Further research into these pathways can inform strategies targeting cell death and proliferation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...